First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Neurotoxins

This is a "connection" page, showing publications Karl-Erik Andersson has written about Neurotoxins.
Connection Strength

0.173
  1. Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol. 2011 Oct; 60(4):784-95.
    View in: PubMed
    Score: 0.087
  2. Hedlund P, Streng T, Lee T, Andersson KE. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. J Urol. 2007 Jul; 178(1):326-31.
    View in: PubMed
    Score: 0.065
  3. Aizawa N, Igawa Y, Andersson KE, Iijima K, Nishizawa O, Wyndaele JJ. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity. Neurourol Urodyn. 2011 Jan; 30(1):163-8.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.